Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing – NDTV

  1. Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing  NDTV
  2. 15 lakh vaccinated in Week 1; Covaxin now in 7 more states  The Indian Express
  3. Seven more states to administer Covaxin from next week: Health Ministry  Financial Express
  4. Bharat Biotech’s Covaxin led to tolerable safety outcomes, enhanced immune responses: Lancet  Times Now
  5. India’s Vaccine Diplomacy Hits Hurdle as Covaxin’s Lack of Efficacy Data Gives Pause to Receiving Nat…  News18
  6. View Full coverage on Google News